On the other hand, AD patients using systemic treatment (e.g., phototherapy, systemic corticosteroids, cyclosporine, methotrexate, azathioprine, JAK inhibitors, and biologics) that could potentially influence the Hsp90 content in the blood were excluded from the study. The gene discussed is HSP90AB1; the disease is Alzheimer disease.